Literature DB >> 7473847

Neuroepidemiology of vascular and Alzheimer's dementia among African-American women.

Y Harris1, P B Gorelick, S Freels, M Billingsley, N Brown, D Robinson.   

Abstract

To better understand risk factors for Alzheimer's disease and vascular dementia, demographic, medical, and other epidemiological factors were compared for 83 African-American women with Alzheimer's disease and 46 with vascular dementia. Overall, the risk-factor profiles for Alzheimer's disease and vascular dementia were similar to those in other studies. However, Alzheimer's patients had a high frequency of hypertension and a relatively high frequency of diabetes mellitus. The presence of such risk factors raises the possibility that there is a vascular component to the dementia in these African-American women with Alzheimer's disease. Neuropathological studies are needed to help answer this question.

Entities:  

Mesh:

Year:  1995        PMID: 7473847      PMCID: PMC2607917     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  14 in total

1.  Risk factors for Alzheimer's disease: overview of the EURODEM collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

Authors:  C M van Duijn; T Stijnen; A Hofman
Journal:  Int J Epidemiol       Date:  1991       Impact factor: 7.196

2.  Cranial computed tomographic observations in multi-infarct dementia. A controlled study.

Authors:  P B Gorelick; A Chatterjee; D Patel; G Flowerdew; W Dollear; J Taber; Y Harris
Journal:  Stroke       Date:  1992-06       Impact factor: 7.914

3.  Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort.

Authors:  D W Desmond; T K Tatemichi; M Paik; Y Stern
Journal:  Arch Neurol       Date:  1993-02

4.  Mortality patterns--United States, 1991.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-11-26       Impact factor: 17.586

5.  Epidemiology of vascular and Alzheimer's dementia among African Americans in Chicago, IL: baseline frequency and comparison of risk factors.

Authors:  P B Gorelick; S Freels; Y Harris; T Dollear; M Billingsley; N Brown
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

6.  Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients.

Authors:  P B Gorelick; J Brody; D Cohen; S Freels; P Levy; W Dollear; H Forman; Y Harris
Journal:  Arch Neurol       Date:  1993-07

7.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

8.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease.

Authors:  P C Davis; L Gray; M Albert; W Wilkinson; J Hughes; A Heyman; M Gado; A J Kumar; S Destian; C Lee
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

9.  Alzheimer's disease: a study of epidemiological aspects.

Authors:  A Heyman; W E Wilkinson; J A Stafford; M J Helms; A H Sigmon; T Weinberg
Journal:  Ann Neurol       Date:  1984-04       Impact factor: 10.422

10.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

View more
  1 in total

1.  Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.

Authors:  Mukaila A Raji; Lynsey P Tamborello; Yong-Fang Kuo; Hyunsu Ju; Jean L Freeman; Dong D Zhang; Sharon H Giordano; James S Goodwin
Journal:  Med Oncol       Date:  2008-12-09       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.